The ABOLISH Study
A clinical research study for people with lower limb spasticity treated with abobotulinum toxin A
The ABOLISH Study is a clinical research study in people diagnosed with lower limb spasticity (LLS). The purpose of the study is to collect information on the use of a medicine called abobotulinum toxin A.
To join the ABOLISH Study, you must:
Be male/female, aged 18 years or older
Have a primary diagnosis of (one-sided) LLS that is not getting worse.
Be able to take more than five steps with or without assistance.
Have not previously been nonresponsive to BoNT-A therapy/have not been treated with BoNT-A within 12 weeks prior to enrollment in the study.
If you are interested in more information about this study, please complete the form below and click the “SUBMIT” button
Melissa Showe, Clinical Research Coordinator will contact you.